文献速递其他结缔组织病

PROMIS在儿童及成人特发性炎症性肌病中显示良好结构效度

PROMIS displays strong construct validity in pediatric and adult patients with idiopathic inflammatory myopathies.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

研究评估PROMIS在幼年及成人特发性炎症性肌病(JIIM/IIM)中的效度,由70名家长、49名患儿及61名成人患者完成PROMIS-49或-57问卷,并与传统健康相关生活质量工具及疾病评估进行关联分析。结果显示各组的躯体功能均低于参考人群,疼痛干扰、疲劳和焦虑显著升高,PROMIS具有优良的内部一致性和结构效度,作者认为可将其纳入IIM/JIIM评估以全面反映患者健康状态。

要点

  • 各组的PROMIS躯体功能评分均低于参考人群,疼痛干扰、疲劳和焦虑评分显著升高。
  • PROMIS内部一致性优良(α>0.9),与传统健康相关生活质量工具的结构效度良好。
  • 家长报告的躯体功能低于患儿、疲劳和焦虑高于患儿;部分PROMIS领域与疾病评估的相关性优于SF-36。

核心结论

  • PROMIS提供了传统疾病评估未能充分捕捉的健康相关生活质量细致视角。
  • PROMIS具有良好的结构效度,可能比传统健康相关生活质量工具更敏感。
  • 作者认为这些发现支持将PROMIS纳入IIM/JIIM评估以全面反映患者健康状态。

研究设计与样本

  • 家长(n=70)、儿童患者(n=49)和成人IIM患者(n=61)完成PROMIS-49或-57问卷。
  • 采用传统健康相关生活质量工具评估结构效度,并分析其与疾病评估及临床特征的相关性。

主要发现

  • 所有组的躯体功能均低于参考人群(39.9-44.3,P<0.001-0.002)。
  • 所有组的疼痛干扰(49.6-55.8,P<0.001)、疲劳(49.5-55.1,P<0.001-0.004)和焦虑(47.0-52.5,P<0.001-0.043)均显著升高。
  • PROMIS具有优良的内部一致性(α>0.9),与传统健康相关生活质量工具的结构效度良好。
  • 家长报告的躯体功能差于患儿(39.7 vs 42.9,P<0.001),疲劳多于患儿(52.4 vs 48.5,P=0.023),焦虑高于患儿(49.6 vs 46.8,P=0.032)。
  • PROMIS躯体功能与疾病活动度指标相关性最好(|r|=0.022-0.636),而社会角色、焦虑和抑郁与疾病活动度指标相关性较差。

关键数值与推荐

  • PROMIS多个领域与患者及家长整体损害相关,但仅家长报告的躯体功能与医生整体损害相关(|r|=0.414)。
  • 多个PROMIS领域与疾病评估的相关性优于医学结局研究简表-36(SF-36)。

临床怎么用

  • 原文结论认为这些发现支持将PROMIS纳入IIM/JIIM评估以全面反映患者健康状态。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We assessed the validity of Patient-Reported Outcome Measurement Information System (PROMIS) for juvenile and adult-onset idiopathic inflammatory myopathies (JIIM/IIM) and determined associations with disease characteristics and assessments. METHODS: PROMIS-49 or -57 questionnaires were completed by parents (n = 70) and pediatric (n = 49) or adult patients with IIM (n = 61). Construct validity was evaluated using legacy health-related quality of life (HRQoL) instruments and associations with disease assessments and clinical characteristics. RESULTS: All groups reported decreased Physical Function (PF) (39.9-44.3, P < 0.001-0.002) compared with the reference population. All groups also reported significantly increased pain interference (49.6-55.8, P < 0.001), fatigue (49.5-55.1, P < 0.001-0.004) and anxiety (47.0-52.5, P < 0.001-0.043). PROMIS demonstrated excellent internal consistency (α > 0.9) and construct validity with legacy HRQoL instruments. Parents reported worse PF (39.7 vs 42.9, P < 0.001), more Fatigue (52.4 vs 48.5, P = 0.023) and higher Anxiety (49.6 vs 46.8, P = 0.032) than their children. PROMIS PF correlated best with disease activity measures (|r|=0.022-0.636), whereas Social Role, Anxiety and Depression correlated poorly with disease activity measures. Multiple PROMIS domains correlated with Patient and Parent Global Damage, but only parent PF correlated with Physician Global Damage (|r|=0.414). Several PROMIS domains had better correlations with disease assessments than the Medical Outcomes Study Short Form-36 (SF-36). CONCLUSION: PROMIS offers a nuanced view of HRQoL that traditional disease assessments do not adequately capture. PROMIS has good construct validity and it may be more sensitive than legacy HRQoL measures. These findings support the incorporation of PROMIS into the assessment of IIM/JIIM to address comprehensive patient well-being.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Austenfeld EM, Sabbagh SE, Liegl M, et al. PROMIS displays strong construct validity in pediatric and adult patients with idiopathic inflammatory myopathies. Rheumatology (Oxford). 2026. PMID: 40996336. doi:10.1093/rheumatology/keaf502

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。